top of page


May 1, 2023

NexEos Bio Names Dawn Rubel as President, Research and Development

April 10, 2020

FDA Grants Orphan Drug Designation to NexEos Bio’s Investigational Radioimaging Agent as a Diagnostic for the Management of Eosinophilic Esophagitis

August 9, 2019

NexEos licenses novel University of Utah imaging tech for diagnosing eosinophil-related inflammation

In the News

March 2023

GIRLBOSS: Through Altitude Lab, these founders received the resources and support they needed to deliver some pretty extraordinary visions for health care to market. They are all working to improve patient care by making it more affordable and accessible. 

March 28, 2023

Pivot Center: University of Utah researcher, Dr. Gerald Gleich of NexEos Bio recognized for decades-long career studying eosinophils

bottom of page